Abrupt Onset, Excessive Hair Fall – Telogen Effluvium
Telogen Effluvium is the formal term for excessive, generalised hair shedding due to an event
Alopecia Areata & other autoimmune conditions
Autoimmune conditions which affect the hair and scalp occur in genetically predisposed individuals, and generally indicate an underlying disturbance or health issue.
Andropause (and other male hormone disturbances)
The male ‘mid-life’ or ‘change of life’ crisishas long been regarded an amusing anecdote; middle-aged
Chronic health or hair loss problems? Methylation may be your answer…
What is Methylation? The Methylation cycle is an essential bio-chemical process which occurs in all mammals to detoxify, synthesise DNA/RNA and repair our cells. Methylation
Current treatment options available for the consumer
Topicals – there are innumerable topical treatments being offered online, in pharmacies; hair salons – even in supermarkets.
Haemochromatosis – what it is and how it affects the hair.
Haemochromatosis is a hereditary disorder where the controlling hormone for iron absorption (hepcidin) is flawed. This causes excessive dietary iron absorption (which is not excreted)
Hair Loss in the Pregnant and Post-Partum Woman
Nothing reveals the unique beauty of a woman quite like a healthy woman displaying her pregnancy. The additional life growing inside her presents a glow
Hormonal (contraceptive) Therapy – its Effects on Hair & Health
When reading a younger female patient’s pathology testing, health providers may note ‘elevated-out-of-normal-reference-range’ Copper levels
Insulin-induced Pattern Hair Loss
From the time I resolved concentrate on female hair loss issues as a professional specialism
Iodine – what it is and why it is SO important for Women
In terms of metabolic importance, Iodine is deemed the next most essential (trace) nutrient after iron and Vitamin D.
Iron deficiency & hair loss – an interpretation
As a continuously growing & metabolically-active tissue, hair requires high levels of
Jak-Inhibitors-in-Trichology
‘Janus kinase’ (JAK) inhibitors are a group of pharmaceutical drug – principally Ruxolitinib/Tofacitinib (1) – which clinical trials have shown